MARKET

ABBV

ABBV

Abbvie Inc
NYSE
232.86
+1.36
+0.59%
After Hours: 233.05 +0.19 +0.08% 16:58 02/17 EST
OPEN
232.66
PREV CLOSE
231.50
HIGH
235.25
LOW
231.19
VOLUME
7.33M
TURNOVER
--
52 WEEK HIGH
241.12
52 WEEK LOW
159.05
MARKET CAP
411.55B
P/E (TTM)
175.70
1D
5D
1M
3M
1Y
5Y
1D
What AbbVie (ABBV)'s Resilient 2025 Results and New Rinvoq Vitiligo Filings Mean For Shareholders
Simply Wall St · 13h ago
AbbVie: Dominating Immunology While Building Oncology Upside
Seeking Alpha · 18h ago
8 Cheap Stocks to Buy in 2026
The Motley Fool · 1d ago
Weekly Report: what happened at ABBV last week (0209-0213)?
Weekly Report · 1d ago
1 No-Brainer Dividend Stock to Buy on the Dip
The Motley Fool · 2d ago
5 Best Stocks to Buy in February
The Motley Fool · 2d ago
3 Dividend Stocks to Hold for the Next 20 Years
The Motley Fool · 2d ago
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off
The Motley Fool · 3d ago
More
About ABBV
AbbVie Inc. is a global, diversified research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Immunology products include rheumatology, dermatology and gastroenterology. Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere and Epkinly. Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and other eye care. Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its investigational candidate, bretisilocin, is for the treatment of patients with moderate-to-severe major depressive disorder (MDD).

Webull offers AbbVie Inc stock information, including NYSE: ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.